Latest U.S. Food and Drug Administration Stories
Expanded U.S. Labeling Offers an Alternative Method to Administer Erwinaze to Patients with ALL DUBLIN, Dec.
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Gastrointestinal Resections PITTSBURGH, Dec.
LOURES, Portugal, December 17, 2014 /PRNewswire/ -- Hovione today announced that the U.S.
ROCKVILLE, Md., Dec. 17, 2014 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
HPPI to commence Phase IIb study in first quarter 2015 of SUBA(TM)-Itraconazole for treatment of basal cell carcinoma in patients with basal cell carcinoma nevus syndrome TAMPA, Fla.
Regulators issued a warning, but no ban; powdered pure caffeine remains readily available. Port Washington, New York (PRWEB) December 12, 2014
RARITAN, N.J. and SAN ANTONIO, Dec.
CALABASAS, Calif., Dec.
Company adds two additional products to its clinical trial roadmap for 2015 SALT LAKE CITY, Dec. 10, 2014 /PRNewswire/ -- Great Basin Scientific, Inc.
Phase One Medical, LLC., a medical device company specializing in the development of venous access products, today announced U.S.
- A transitional zone between two communities containing the characteristic species of each.